Todd Watanabe sold $506K of Arcutis Biotherapeutics (ARQT)

Executed Feb 2, disclosed Feb 4, 2 days later.

Value, as filed

$506K

19,833 sh × $25.50

Executed

Feb 2

the trade date, as filed

Disclosed

Feb 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Todd Watanabe See Remarks profile →

Todd Watanabe (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.5M of ARQT (48,945 sh × $30.36, as filed), executed Nov 24 2025.

The name

ARQT

Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Todd Watanabe in ARQT

ARQTSALE Arcutis Biotherapeutics, Inc. $139K
4,377 sh × $31.86
Exec Nov 2
Filed Nov 4 · 6:38 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $114K
4,375 sh × $26.12
Exec Aug 3
Filed Aug 5 · 9:42 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $913K
36,281 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $1.5M
48,945 sh × $30.36
Exec Nov 24 2025
Filed Nov 24 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $284K
11,478 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $1.0M
40,000 sh × $25.03
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $885K
45,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $169K
9,625 sh × $17.54
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET